Endohope Havirov s.r.o.
- Address
- Dlouha Trida 1134/83, Podlesí, 736 01 Havířov, Czechia
Digestive System Diseases and Inflammatory Bowel Disease
At Endohope Havirov s.r.o., clinical research in digestive system diseases focuses on ulcerative colitis, with studies designed to assess new treatment options and compare their effectiveness for people living with active intestinal inflammation.
- Moderate to severe active ulcerative colitis
- Testing therapies aimed at improving disease control and symptom relief
- Comparing established and emerging treatments for effectiveness and safety
These trials support better care for patients with difficult-to-manage inflammatory bowel disease by evaluating whether newer approaches can offer meaningful clinical benefit.
Nutritional and Metabolic Diseases
Research in nutritional and metabolic diseases at this site includes studies in coeliac disease and chronic weight management, reflecting a focus on both intestinal health and metabolic health outcomes.
- Coeliac disease and non-responsive forms of the condition
- Chronic weight management in adults with overweight or obesity
- Evaluating therapies that may improve intestinal recovery or support weight reduction
These clinical trials aim to improve treatment effectiveness, reduce disease-related complications, and expand options for patients who need better long-term management.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Endohope Havirov s.r.o.
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Comparative Efficacy, Safety, and Immunogenicity of Intravenous AVT16 Versus Vedolizumab in Adults with Moderate to Severe Active Ulcerative Colitis | Alvotech Swiss AG | Phase III | Not Recruiting | Aug 2025 | Oct 2025 |
IMP list
lock Showing 1 of 5 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Amlitelimab | 1 | Unknown | 2024-10-15 | 2024-10-15 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.